Quantitative assessment of markers of inflammation, arthritis and pain in rats with adjuvant arthritis following the treatment with ibuprofen cream and placebo

Drugs under Experimental and Clinical Research

Volumn 29, Issue 2, 2003, Pages 85-90

  Rovenský, Josef ^a   Svik K ^a   Istok R ^a   Stancikova M ^a  

^a NATIONAL INSTITUTE OF RHEUMATIC DISEASES   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN; PLACEBO; SERUM ALBUMIN;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTHROGRAPHY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; INFLAMMATION; MALE; NONHUMAN; PAIN; PAIN THRESHOLD; PAW EDEMA; QUANTITATIVE ANALYSIS; RAT; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, EXPERIMENTAL; BIOLOGICAL MARKERS; BODY WEIGHT; IBUPROFEN; INFLAMMATION; MALE; OINTMENTS; PAIN; PAIN THRESHOLD; RATS; RATS, INBRED LEW; SERUM ALBUMIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 0042027947     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Chlud K., Wagener H.H. Percutaneous therapy with non-steroidal anti-rheumatic drug (NSAID) with particular reference to pharmacokinetic factors. EULAR Bull., 2, 40, 1987.
2. Treffel P., Gabard B. Ibuprofen epidermal levels after topical application in vitro: Effect of formulation, application time, dose variation and occlusion. Br. J. Dermatol., 129, 286, 1993.
3. Dreiser R.L. Etude clinique de l'efficacité et de la tolérance de l'ibuprofène percutané dans le traitement des tenditides. J. Int. Méd. (Paris), 119, 15, 1988.
4. Billigman P.W., Chlud K., Schreyger F., Vögtle-Junkert U. Topical ibuprofen against pain in distorions (in German). Top Medizin, 12, 24, 2002.
5. Pazzaglia U.E. Topical therapies in tendopathies. Therapiewoche, 42, 1636, 1992.
6. Ramesh N.K., Steuber U. Dolgit Creme bei Unfall- und Sportverletzungen. Therapiewoche, 33, 4563, 1983.
7. Chlud K. Use of topical non-steroidal anti-inflammatory drugs in aggravated and decompensated arthroses (in German). Wien Med. Wochenschr., 149, 546, 1999.
8. Rovensky J., Micekova D., Gubzova Z., et al. Treatment of knee osteoarthritis with a topical non-steroidal antiinflammatory drug. Results of a randomized, double-blind, placebo-controlled study on the efficacy and safety of a 5% ibuprofen cream. Drugs Exptl. Clin. Res., 27, 209, 2001.
9. Berner G., Engels B., Vögtle-Junken U. Percutaneous ibuprofen therapy with Trauma-Dolgit gel: Bioequivalence studies. Drug Exptl. Clin. Res., 15, 559, 1989.
10. Arendt-Nielsen L., Drewes A.M., Svendsen L., Brennum J. Quantitative assessment of joint pain following treatment of rheumatoid arthritis with ibuprofen cream. Scand. J. Rheumatol., 23, 334, 1994.
11. Price D.D., Mao J., Lu J., Caruso F.S., Frenk H., Mayer D.J. Effect of the combined administration of NSAIDs and dextromethorphan on behavioral symptoms indicative of arthritis pain in rats. Pain, 68, 119, 1996.
12. Lichtenberger L.M., Romero J.J., de Ruijter W.M.J., et al. Phosphatidylcholine association increases the anti-inflammatory and analgesic activity of ibuprofen in acute and chronic rodent models of joint inflammation relationship to alterations in bioavaibility and cyclooxygenase-inhibitory potency. Pharmacol. Exp. Therapeutics, 298, 279, 2001.
13. Selph J.L., Boncek V.M., Soroko F.E., Harris T.M., Cochran F.R. The pharmacologic evaluation of locomotor activity versus inflammatory parameters in rat adjuvant arthritis. Agents Actions, 39, 201, 1993.